Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
FDA advisers, frustrated by AZ's Imfinzi design, call for revamp of perioperative lung cancer trials
Fierce Pharma
Thu, 07/25/24 - 09:59 pm
FDA
ODAC
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
Yahoo/Benzinga
Thu, 07/25/24 - 11:07 am
AstraZeneca
earnings
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
BioSpace
Wed, 07/24/24 - 11:32 am
AstraZeneca
Imfinzi
non-small cell lung cancer
FDA
AstraZeneca plants an EGFR tree with Pinetree deal worth $45M
Fierce Biotech
Tue, 07/23/24 - 06:24 pm
AstraZeneca
Pinetree Therapeutics
EGFR
J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses
Fierce Pharma
Tue, 07/16/24 - 12:00 pm
Inflation Reduction Act
Medicare
drug pricing
JNJ
Bristol Myers Squibb
AstraZeneca
AstraZeneca appoints WPP as one of its primary oncology network partners
Medical Marketing and Media
Wed, 07/10/24 - 11:15 am
AstraZeneca
WPP
oncology
advertising
AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Clinical Trials Arena
Mon, 07/8/24 - 11:33 am
AstraZeneca
Aptamer Group
siRNA
AstraZeneca files rival to Pemgarda for COVID PrEP
Pharmaphorum
Mon, 07/1/24 - 11:08 am
AstraZeneca
COVID-19
COVID PrEP
sipavibart
AstraZeneca’s Imfinzi fails adjuvant trial in lung cancer
Pharmaphorum
Tue, 06/25/24 - 11:25 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
Supreme Court gives pharma giants another chance to sidestep terrorism-funding case
Fierce Pharma
Mon, 06/24/24 - 10:08 pm
legal
AstraZeneca
GE Healthcare
JNJ
Pfizer
Roche
terrorism
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial
BioSpace
Tue, 06/18/24 - 11:46 am
AstraZeneca
Truqap
triple-negative breast cancer
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Reuters
Mon, 06/17/24 - 11:31 am
AstraZeneca
Imfinzi
endometrial cancer
FDA
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena
Mon, 06/17/24 - 11:21 am
AstraZeneca
clinical trials
Calquence
MCL
mantle cell lymphoma
ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
Fierce Pharma
Mon, 06/3/24 - 12:10 pm
ASCO 2024
AstraZeneca
Tagrisso
Imfinzi
lung cancer
non-small cell lung cancer
ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer
Fierce Pharma
Sun, 06/2/24 - 02:46 pm
ASCO 2024
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
AstraZeneca throws its hat into the oral PCSK9 ring
Pharmaphorum
Wed, 05/29/24 - 11:28 am
AstraZeneca
PCSK9 inhibitors
cholesterol
AZD0780
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Amgen
AstraZeneca
biosimilars
Soliris
Bkemv
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far?
BioSpace
Fri, 05/24/24 - 11:14 am
AstraZeneca
R&D
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »